ELV Elevance Health

Q3 2025 10-Q

Filed: Oct 21, 2025Period ending Sep 30, 2025

Financials

Hospital & Medical Service PlansSEC EDGAR

Elevance Health (ELV) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 21, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue $50.1B Q3 2025, up 12.0% YoY ($44.7B Q3 2024); $148.3B YTD, up 13.9% YoY ($130.2B YTD 2024)
• Operating margin 2.6% Q3 2025 vs 3.1% Q3 2024; YTD margin 4.6% vs 5.5% YoY; Health Benefits margin down to 1.4% Q3 from 4.2% YoY

+3 more insights

Risk Factors

• No new or changed risk factors since 2024 Annual Report on Form 10-K
• Regulatory risk: ongoing potential adverse impact from healthcare laws and government policy changes

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$50.7B

Net Income

$1.2B

Operating Margin

2.6%

Net Margin

2.3%

ROE

2.7%

Total Assets

$122.7B

Source: XBRL data from Elevance Health Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Elevance Health

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.